See more : Nuformix plc (NFX.L) Income Statement Analysis – Financial Results
Complete financial analysis of The Cannabist Company Holdings Inc. (CBSTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Cannabist Company Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Sensei Biotherapeutics, Inc. (SNSE) Income Statement Analysis – Financial Results
- aTyr Pharma, Inc. (ATYR) Income Statement Analysis – Financial Results
- RF Capital Group Inc. (RCG-PB.TO) Income Statement Analysis – Financial Results
- ION Geophysical Corporation (IOGPQ) Income Statement Analysis – Financial Results
- Reliq Health Technologies Inc. (RQHTF) Income Statement Analysis – Financial Results
The Cannabist Company Holdings Inc. (CBSTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cannabistcompany.com
About The Cannabist Company Holdings Inc.
The Cannabist Company Holdings Inc. engages in the cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The company was founded in 2012 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 511.33M | 491.31M | 456.03M | 188.99M | 79.26M | 347.78K |
| Cost of Revenue | 331.36M | 355.18M | 309.11M | 136.30M | 65.79M | 2.29M |
| Gross Profit | 179.97M | 136.13M | 146.92M | 52.68M | 13.47M | -1.94M |
| Gross Profit Ratio | 35.20% | 27.71% | 32.22% | 27.88% | 16.99% | -558.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 158.85M | 203.69M | 179.48M | 130.22M | 103.98M | 0.00 |
| Selling & Marketing | 5.39M | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
| SG&A | 164.23M | 209.23M | 184.62M | 137.13M | 109.77M | 0.00 |
| Other Expenses | 120.98M | -3.04M | -1.33M | 368.00K | 0.00 | -807.59K |
| Operating Expenses | 285.21M | 209.23M | 184.62M | 137.13M | 109.77M | 807.59K |
| Cost & Expenses | 616.57M | 564.41M | 493.73M | 273.43M | 175.56M | 3.10M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.24M | 0.00 |
| Interest Expense | 54.87M | 53.90M | 30.01M | 6.34M | 0.00 | 0.00 |
| Depreciation & Amortization | 62.73M | 81.43M | 52.54M | 20.69M | 15.54M | 0.00 |
| EBITDA | -52.24M | -282.36M | -63.14M | -115.66M | -95.21M | -2.75M |
| EBITDA Ratio | -10.22% | 1.69% | 3.25% | -33.74% | -101.89% | -790.95% |
| Operating Income | -105.24M | -73.10M | -37.70M | -84.45M | -96.30M | -2.75M |
| Operating Income Ratio | -20.58% | -14.88% | -8.27% | -44.69% | -121.50% | -790.95% |
| Total Other Income/Expenses | -63.66M | -16.45M | -36.35M | -55.63M | 261.95K | 0.00 |
| Income Before Tax | -168.90M | -415.55M | -145.42M | -143.02M | -96.04M | -2.75M |
| Income Before Tax Ratio | -33.03% | -84.58% | -31.89% | -75.68% | -121.17% | -790.95% |
| Income Tax Expense | 5.39M | -10.77M | 137.78K | -17.05M | 13.17M | 0.00 |
| Net Income | -175.71M | -399.52M | -141.84M | -100.85M | -104.97M | -2.75M |
| Net Income Ratio | -34.36% | -81.32% | -31.10% | -53.36% | -132.44% | -790.95% |
| EPS | -0.44 | -1.02 | -0.42 | -0.43 | -0.50 | -0.01 |
| EPS Diluted | -0.44 | -1.02 | -0.42 | -0.43 | -0.50 | -0.01 |
| Weighted Avg Shares Out | 402.78M | 392.57M | 338.75M | 232.58M | 209.99M | 209.99M |
| Weighted Avg Shares Out (Dil) | 402.78M | 392.57M | 338.75M | 232.58M | 209.99M | 209.99M |
The Cannabist Company Makes Sense To Buy Again
The Sustainability Of Cannabis Bull Run
Source: https://incomestatements.info
Category: Stock Reports